Hideki Garren, Chief Medical Officer at PROTHENA CORP PUBLIC LTD CO (PRTA), sold 8,174 shares at $74.59 ($607K) on 2023-06-14, disclosed to the SEC on 2023-06-14.
Scheduled sale ($607k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $72.45 | 509 | $37K | 6.1% |
| 2 | $73.31 | 971 | $71K | 11.7% |
| 3 | $73.31 | 971 | $71K | 11.7% |
| 4 | $74.59 | 2,534 | $189K | 31.2% |
| 5 | $74.59 | 2,534 | $189K | 31.2% |
| 6 | $75.49 | 655 |
| $49K |
| 8.1% |
| Total | $74.22 avg | 8,174 | $607K | 100% |
| Filing → |
| PRTA | SELL | 2023-07-12 | $264K | — | Filing → |
| PRTA | SELL | 2023-06-16 | $542K | — | Filing → |
| PRTA | SELL | 2023-03-17 | $581K | — | Filing → |